Moderna Inc (MRNA)vsMatinas BioPharma Holdings Inc (MTNB)
MRNA
Moderna Inc
$143.97
+5.38%
HEALTHCARE · Cap: $56.02B
MTNB
Matinas BioPharma Holdings Inc
$0.19
-9.27%
HEALTHCARE · Cap: $2.66M
Smart Verdict
WallStSmart Research — data-driven comparison
MTNB leads profitability with a 0.0% profit margin vs -141.4%. MTNB earns a higher WallStSmart Score of 21/100 (F).
MRNA
Avoid21
out of 100
Grade: F
MTNB
Avoid21
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+70.0%
Fair Value
$134.97
Current Price
$143.97
$9.00 discount
Intrinsic value data unavailable for MTNB.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Conservative balance sheet, low leverage
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
Trading at 8.5x book value
2.1% revenue growth
Weak financial health signals
ROE of -46.6% — below average capital efficiency
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : MRNA
The strongest argument for MRNA centers on Market Cap, Debt/Equity.
Bull Case : MTNB
The strongest argument for MTNB centers on Price/Book, Debt/Equity.
Bear Case : MRNA
The primary concerns for MRNA are Price/Book, Revenue Growth, Piotroski F-Score.
Bear Case : MTNB
The primary concerns for MTNB are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
MRNA profiles as a turnaround stock while MTNB is a value play — different risk/reward profiles.
MTNB carries more volatility with a beta of 1.70 — expect wider price swings.
MRNA is growing revenue faster at 2.1% — sustainability is the question.
MTNB generates stronger free cash flow (-2M), providing more financial flexibility.
Bottom Line
MRNA scores higher overall (21/100 vs 21/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Moderna Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Matinas BioPharma Holdings Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery and development of several candidate products. The company is headquartered in Bedminster, New Jersey.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?